Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
A number of firms have modified their ratings and price targets on shares of AstraZeneca (LON: AZN) recently: 4/8/2022 – AstraZeneca was given a new £110 ($144.26) price target on by analysts at Credit Suisse Group AG. 4/7/2022 – AstraZeneca was given a new £120 ($157.38) price target on by analysts at JPMorgan Chase & […]
Deutsche Bank Rese… set a £115 ($150.82) price target on AstraZeneca (LON:AZN – Get Rating) in a report published on Wednesday, Borsen Zeitung reports. AZN has been the subject of several other reports. Barclays reissued an overweight rating and issued a £115 ($150.82) target price on shares of AstraZeneca in a research report on Monday, […]
AstraZeneca (LON:AZN – Get Rating)‘s stock had its “overweight” rating restated by JPMorgan Chase & Co. in a research note issued on Tuesday, MarketBeat reports. They presently have a £100 ($131.15) price target on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 4.42% from the company’s current […]